Association of brain-derived neurotrophic factor genetic val66met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in chinese major depressive patients

Neuropsychobiology

Volumn 61, Issue 2, 2010, Pages 71-78

  Zou, Yan Feng ^a   Wang, Yu ^b   Liu, Ping ^b   Feng, Xiao Liang ^a,b   Wang, Bin Yan ^b   Zang, Tong Hua ^b   Yu, Xin ^c   Wei, Jing ^d   Liu, Zhong Chun ^e   Liu, Ying ^f   Tao, Ming ^g   Li, Hui Chun ^h   Li, Ke Qing ⁱ   Hu, Jian ^j   Li, Ming ^k   Zhang, Ke Rang ^l   Ye, Dong Qing ^a   Xu, Xi Ping ^b  

^a School of Nursing and Mailman

^b ANHUI MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g Seventh Hospital of Hangzhou   (China)

^h ZHEJIANG UNIVERSITY   (China)

ⁱ Sixth People's Hospital of Hebei Province   (China)

^j HARBIN MEDICAL UNIVERSITY   (China)

^k Suzhou Guangji Hospital   (China)

^l SHANXI MEDICAL UNIVERSITY   (China)

more..

Author keywords

Brain derived neurotrophic factor; Major depressive disorder; Polymorphism; Selective serotonin reuptake inhibitor; Treatment response

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAMILTON SCALE; HETEROZYGOSITY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; VALINE; YOUNG ADULT;

EID: 72049090168     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265132     Document Type: Article

References (49)

1. Ustun TB: The Worldwide Burden of Depression in the 21st Century. Washington, American Psychiatric Press, 2001.
2. Driscoll HC, Basinski J, Mulsant BH, Butters MA, Dew MA, Houck PR, Mazumdar S, Miller MD, Pollock BG, Stack JA, Schlernitzauer MA, Reynolds CF 3rd: Late-onset major depression: clinical and treatment-response variability. Int J Geriatr Psychiatry 2005; 20: 661-667.
3. Lotrich FE, Pollock BG: Aging and clinical pharmacology: implications for antidepressants. J Clin Pharmacol 2005; 45: 1106-1122.
4. Whyte EM, Dew MA, Gildengers A, Lenze EJ, Bharucha A, Mulsant BH, Reynolds CF: Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging 2004; 21: 531-554.
5. Serretti A, Artioli P, Quartesan R: Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Pharmacogenet Genomics 2005; 15: 61-67.
6. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539-7547.
7. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM: Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137.
8. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265.
9. Mowla SJ, Farhadi HF, Pareek S, Atwal JK, Morris SJ, Seidah NG, Murphy RA: Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 2001; 276: 12660-12666.
10. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, De La Monte SM, Squinto S, Furth ME, Yancopoulos GD: Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991; 10: 558-568.
11. Ozcelik T, Rosenthal A, Franke U: Chromosomal mapping of brain-derived neurotrophic factor and neurotrophin-3 genes in man and mouse. Genomics 1991; 10: 569-575.
12. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, Gennarelli M: Association between the BDNF 196A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002; 7: 136-137.
13. Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, Kanazawa I, Toda T: Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002; 51: 133-136.
14. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL: The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2001; 71: 651-655.
15. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic- factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 2003; 123B:19-22.
16. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS: Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 2006; 1118: 176-182.
17. Yoshida K, Higuchi H, Kamata M, Takahashi H, Inoue K, Suzuki T, Itoh K, Ozaki N: The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine. J Psychopharmacol 2007; 21: 650-656.
18. Gratacòs M, Soria V, Urretavizcaya M, González JR, Crespo JM, Bayés M, De Cid R, Menchón JM, Vallejo J, Estivill X: A brainderived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders. Pharmacogenomics J 2008; 8: 101-112.
19. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
20. Guy W: ECDEU Assessment Manual for Psychopharmacology. Rockville, National Institutes of Health, Psychopharmacology Research Branch, 1976.
21. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999; 22: 231-238.
22. Shimizu E, Hashimoto K, Iyo M: Ethnic difference of the BDNF 196G/A (Val66Met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 2004; 126: 122-123.
23. Itoh K, Hashimoto K, Kumakiri C, Shimizu E, Iyo M: Association between brain-derived neurotrophic factor 196G/A polymorphism and personality traits in healthy subjects. Am J Med Genet B Neuropsychiatr Genet 2004; 124: 61-63. (Pubitemid 38031595)
24. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
25. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM: Neurobiology of depression. Neuron 2002; 34: 13-25.
26. Lee BH, Kim H, Park SH, Kim YK: Decreased plasma BDNF level in depressive patients. J Affect Disord 2007; 101: 239-244.
27. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP: Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 2001; 120: 87-95.
28. Xu H, Qing H, Lu W, Keegan D, Richardson JS, Chlan-Fourney J, Li XM: Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 2002; 321: 65-68.
29. Linnarsson S, Björklund A, Ernfors P: Learning deficit in BDNF mutant mice. Eur J Neurosci 1997; 9: 2581-2587.
30. Malberg JE, Eisch AJ, Nestler EJ, Duman RS: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20: 9104-9110.
31. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
32. Foltynie T, Lewis SG, Goldberg TE, Blackwell AD, Kolachana BS, Weinberger DR, Robbins TW, Barker RA: The BDNF Val- 66Met polymorphism has a gender-specific influence on planning ability in Parkinson's disease. J Neurol 2005; 252: 833-838.
33. Dagher A, Owen AM, Boecker H, Brooks DJ: Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 1999; 122: 1973-1987.
34. Sullivan PF: Spurious genetic associations. Biol Psychiatry 2007; 61: 1121-1126.
35. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B: Discontinuing or switching selective serotonin-reuptake inhibitors. Ann Pharmacother 2002; 36: 578-584.
36. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63: 357-366.
37. Montejo AL, Llorca G, Izquierdo JA, Rico- Villademoros F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1,022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62: 10-21.
38. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-544. (Pubitemid 29081307)
39. Chen KC, Minor TX, Rahman NU, Ho HC, Nunes L, Lue TF: The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model or neurogenic impotence. BJU Int 2005; 95: 1077-1080.
40. Mitsui T, Fischer I, Shumsky JS, Murray M: Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats. Exp Neurol 2005; 194: 410-431.
41. Cirelli C, Gutierrez CM, Tononi G: Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron 2004; 41: 35-43.
42. Cirelli C, Bushey D, Hill S, Huber R, Kreber R, Ganetzky B, Tononi G: Reduced sleep in Drosophila Shaker mutants. Nature 2005; 434: 1087-1092.
43. Terao A, Wisor JP, Peyron C, Apte-Deshpande A, Wurts SW, Edgar DM, Kilduff TS: Gene expression in the rat brain during sleep deprivation and recovery sleep: an Affymetrix GeneChip study. Neuroscience 2006; 137: 593-605.
44. Cirelli C: How sleep deprivation affects gene expression in the brain: a review of recent findings. J Appl Physiol 2002; 92: 394-400.
45. Faraguna U, Vyazovskiy VV, Nelson AB, Tononi G, Cirelli C: A causal role for brainderived neurotrophic factor in the homeostatic regulation of sleep. J Neurosci 2008; 28: 4088-4095.
46. Albinsson A, Andersson G, Andersson K, Vega-Matuszczyk J, Larsson K: The effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and locomotor activity. Behav Brain Res 1996; 80: 57-63.
47. Tagliamonte A, Tagliamonte P, Gessa GL, Brodie BB: Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science 1969; 166: 1433-1435.
48. Mössner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, Lesch KP: Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 2000; 36: 197-202.
49. Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, Rosenbaum JF, Fava M: Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 2003; 54: 879-883.